Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4262657 | 0.74 | — | — | |
| SCHEMBL3282927 | 0.74 | — | — | |
| SCHEMBL28058653 | 0.74 | — | — | |
| SCHEMBL3636886 | 0.74 | — | — | |
| SCHEMBL27643362 | 0.74 | — | — | |
| SCHEMBL1849977 | 0.74 | — | — | |
| SCHEMBL174098 | 0.74 | — | — | |
| SCHEMBL15292025 | 0.74 | — | — | |
| SCHEMBL14696607 | 0.72 | L3MBTL1 (0.53) | L3MBTL1ALDH1A1HTR2AHTR2CHTR2B | |
| SCHEMBL22616127 | 0.71 | L3MBTL1 (0.41) | L3MBTL1ALDH1A1HTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118105738-A | Preparation method of novel anionic demulsifier for cutting fluid wastewater treatment | 苏州顿莱环保科技有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-117964435-A | High-energy composite explosive and preparation method thereof | 江西省第十一建设有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-116874585-B | Synthesis method of insulin detention | 杭州湃肽生化科技有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-110142025-B | Ionic liquid, application thereof, modified activated carbon and preparation method thereof | 河北科技大学 | 2022-02-15 | — | — | CN | claimed |
| CN-110550616-A | Energy-containing eutectic solvent, application thereof, metal-doped carbon quantum dot prepared from energy-containing eutectic solvent and preparation method of metal-doped carbon quantum dot | UNIV HEBEI SCIENCE & TECH | 2019-12-10 | — | — | CN | claimed |
| EP-2323990-B1 | METHODS FOR THE PRODUCTION OF 2-HALO-4-NITROIMIDAZOLE AND INTERMEDIATES THEREOF | DYNAMIT NOBEL AG (DE) | 2014-06-18 | — | — | EP | claimed |
| US-8558005-B2 | Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) | 2013-10-15 | — | — | US | claimed |
| US-8119679-B2 | Method for preparation of 2,4-dinitroimidazole which is an intermediate for insensitive meltcastable molecular explosive | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2012-02-21 | — | — | US | claimed |
| JP-2012500183-A | — | — | 2012-01-05 | — | — | JP | claimed |
| US-20110275830-A1 | METHOD FOR PREPARATION OF 2,4-DINITROIMIDAZOLE WHICH IS AN INTERMEDIATE FOR INSENSITIVE MELTCASTABLE MOLECULAR EXPLOSIVE | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2011-11-10 | — | — | US | claimed |
| US-20110178308-A1 | METHODS FOR THE PRODUCTION OF 2-HALO-4-NITROIMIDAZOLE AND INTERMEDIATES THEREOF | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2011-07-21 | — | — | US | claimed |
| EP-2323990-A1 | METHODS FOR THE PRODUCTION OF 2-HALO-4-NITROIMIDAZOLE AND INTERMEDIATES THEREOF | Dynamit Nobel GmbH Explosivstoff- und Systemtechnik (DE) | 2011-05-25 | — | — | EP | claimed |
| WO-2010143007-A1 | METHOD FOR THE PRODUCTION OF 2-HALOGENO-4-NITROIMIDAZOLE | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) | 2010-12-16 | — | — | WO | claimed |
| WO-2010021409-A1 | METHODS FOR THE PRODUCTION OF 2-HALO-4-NITROIMIDAZOLE AND INTERMEDIATES THEREOF | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF - UND SYSTEMTECHNIK (DE) | 2010-02-25 | — | — | WO | claimed |
| US-5387297-A | 2,4-dinitroimidazole- a less sensitive explosive and propellant made by thermal rearrangement of molten 1,4 dinitroimidazole | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1995-02-07 | — | — | US | claimed |
| US-12545649-B2 | WDR5-MYC inhibitors | VANDERBILT UNIVERSITY (US) | 2026-02-10 | — | — | US | disclosed |
| CN-119504601-A | Abnormal-shape difunctional crosslinking agent and preparation method and application thereof | 南昌大学 | 2025-02-25 | — | — | CN | disclosed |
| WO-1999008699-A1 | GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 1999-02-25 | — | — | WO | disclosed |
| WO-1999008697-A1 | TREATMENT OF CONGESTIVE HEART FAILURE WITH GROWTH HORMONE SECRETAGOGUES | ELI LILLY AND COMPANY (US) | 1999-02-25 | — | — | WO | disclosed |
| US-5387297-A | 2,4-dinitroimidazole- a less sensitive explosive and propellant made by thermal rearrangement of molten 1,4 dinitroimidazole | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1995-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545649-B2 | WDR5-MYC inhibitors | MYC, MYCBP, WDR1 | L3MBTL1 517/4885ALDH1A1 4135/4885HTR2A 3874/4885 |
| US-20110178308-A1 | METHODS FOR THE PRODUCTION OF 2-HALO-4-NITROIMIDAZOLE AND INTERMEDIATES THEREOF | IL4I1, NUDT1, NISCH | L3MBTL1 3231/4885ALDH1A1 704/4885HTR2A 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.